GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms

Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting millions of patients worldwide. Many therapeutics are available for treating PD symptoms but there is no disease-modifying therapeutic that has been unequivocally shown to slow or stop the progression of the disease. Ther...

Descripción completa

Detalles Bibliográficos
Autor principal: Schneider, Jay S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252733/
https://www.ncbi.nlm.nih.gov/pubmed/37298133
http://dx.doi.org/10.3390/ijms24119183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252733/
https://www.ncbi.nlm.nih.gov/pubmed/37298133
http://dx.doi.org/10.3390/ijms24119183

Ejemplares similares